Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
303 Leser
Artikel bewerten:
(1)

Endoscope Reprocessing Market Value to Surpass $4,358.1 Million by 2030, says P&S Intelligence

NEW YORK, July 14, 2022 /PRNewswire/ -- According to the latest market research study published by P&S Intelligence, in 2021, the global endoscope reprocessing market was worth around $1,879.9 million, and it is predicted to hit $4,358.1 million by 2030, progressing at a 9.8% CAGR from 2021 to 2030. This is primarily due to the growing preference for minimally invasive treatments, increasing danger of infection by contaminated endoscopes, and rising stringency of the rules governing medical device safety on a global scale.

P_and_S_Intelligence_Logo

To avoid the complications and extra costs related to the different services offered under contracts with medical equipment manufacturers, end users are increasingly entering into multi-vendor contracts with ISOs. For example, customers may combine all of NovaMed Corporation's services under a single contract, owing to its extensive service management program.

Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/endoscope-reprocessing-market/report-sample

Geographical Analysis

With an estimated contribution of $1.0 billion, North America leads the endoscope reprocessing market. This is due to the region's advantageous reimbursement policies, increase in cancer incidence, and demand for less-invasive procedures. Additionally, the existence of large medical device manufacturers, including Stryker Corporation, Boston Scientific Corporation, Cantel Medical Corp., and Conmed Corporation, makes it simple to find both endoscopes and OEM repair services.

The APAC endoscope reprocessing market is predicted to grow with more than 10.0% CAGR in this decade because of the rise in the volume of endoscopic procedures and improvements in the healthcare system. Additionally, in 2021, China and Japan together held around 50% share in the region, because of the high prevalence of GI-related malignancies in both nations.

Browse detailed report on Endoscope Reprocessing Market Size, New Trends, Emerging Opportunities, and Top Key Company By 2030

Segmentation Analysis

Flexible endoscopes account for the majority of the demand for reprocessing, which is why they held approximately 65.0% share in 2021. This is due to the active release of automated endoscope reprocessors by the leading companies, which are rather compatible with flexible endoscopes.

Due to the rising incidence of infections, including pneumonia and bacteremia, after the usage of endoscopies, the high-level disinfectants and test strip category had an around 35% market share in 2021.

Laparoscopes have a more than 40% endoscope reprocessing market share for rigid endoscopes, as a result of the growing preference for less-invasive operations. This is, in turn, due to their numerous advantages, including fewer post-operative problems and faster recovery compared to open surgeries.

The hospitals category is predicted to grow with around 11% CAGR. This may be ascribed to the increase in the number of endoscopic operations, growth in the count of hospitals throughout the world, and distribution of funding and investments from government organizations.

Endoscope Reprocessing Market Report Coverage

By Product

  • High-Level Disinfectants & Test Strips
  • Detergents & Wipes
  • Automated Endoscope Reprocessors
  • Endoscope Drying, Storage, & Transport Systems
  • Endoscope Tracking Solutions

By Type

  • Flexible
    • Upper gastrointestinal endoscopes
    • Colonoscopes
    • Bronchoscopes
    • Sigmoidoscopes
    • Laryngoscopes
    • Duodenoscopes
    • Nasopharyngoscopes
    • Rhinoscopes
  • Rigid
    • Laparoscopes
    • Ureteroscopes
    • Gynecology endoscopes
    • Arthroscopes
    • Cystoscopes
    • Neuroendoscopes

By End User

  • Hospitals
  • Ambulatory Surgical Centers and Clinics

Regional Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • Saudi Arabia
    • South Africa

Browse Other Related Reports Published by P&S

Endoscope Market Recent Trends, Developments and Opportunities

U.S. Endoscope Repair Market Recent Trends, Developments and Opportunities

Diagnostic Imaging Systems Market Recent Trends, Developments and Opportunities

North America Diagnostic Imaging Systems Market Recent Trends, Developments and Opportunities

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

Contact:
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/1224988/P_and_S_Intelligence_Logo.jpg

© 2022 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.